Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology
Read more at globenewswire.com
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Provided By GlobeNewswire - Last update: Aug 31, 2025
Article Mentions:
60.41
-1.78 (-2.86%)
Find more stocks in the Stock Screener
CYTK Latest News and Analysis
12 days ago - By: Chartmill
